What is the stock price forecast for atra in 2030?
ATRA Stock 12 Months Forecast
Based on 3 Wall Street analysts offering 12 month price targets for Atara Biotherapeutics in the last 3 months. The average price target is $7.00 with a high forecast of $13.00 and a low forecast of $1.00. The average price target represents a 1027.58% change from the last price of $0.62.
What is the future of ATRA stock?
ATRA Stock 12 Months Forecast
Based on 3 Wall Street analysts offering 12 month price targets for Atara Biotherapeutics in the last 3 months. The average price target is $7.00 with a high forecast of $13.00 and a low forecast of $1.00. The average price target represents a 1027.58% change from the last price of $0.62.
Is ATRA a good stock to buy?
Out of 2 analysts, 0 (0%) are recommending ATRA as a Strong Buy, 0 (0%) are recommending ATRA as a Buy, 1 (50%) are recommending ATRA as a Hold, 0 (0%) are recommending ATRA as a Sell, and 1 (50%) are recommending ATRA as a Strong Sell. If you're new to stock investing, here's how to buy Atara Biotherapeutics stock.
What is the open stock price prediction for 2030?
| Year | Prediction | Change |
|---|---|---|
| 2027 | $ 9.00 | 236.97% |
| 2028 | $ 13.49 | 405.20% |
| 2029 | $ 20.22 | 657.40% |
| 2030 | $ 30.32 | 1,035.51% |
What will Mara be worth in 2025?
| Year | Prediction | Change |
|---|---|---|
| 2025 | $ 49.76 | 153.15% |
| 2026 | $ 125.96 | 540.87% |
| 2027 | $ 318.88 | 1,522.38% |
| 2028 | $ 807.25 | 4,007.10% |
What is the stock price forecast for ATRA in 2024?
According to our current ATRA stock forecast, the value of Atara Biotherapeutics shares will drop by -2.95% and reach $ 0.602489 per share by March 20, 2024. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear).
Why is ATRA stock dropping?
Atara Biotherapeutics (ATRA) stock is falling on Thursday after failing a Phase 2 clinical trial. The study didn't meet its primary endpoint.
Is Atara a buy or sale?
Atara Biotherapeutics stock has received a consensus rating of buy. The average rating score is and is based on 9 buy ratings, 3 hold ratings, and 5 sell ratings.
What penny stocks to buy today?
| Company Name | LTP | % Change |
|---|---|---|
| Kanani Industries | 3.9 | -2.50 |
| Dynamic Cables Ltd | 363.95 | -0.52 |
| Hilton Metal Forging | 112.05 | 1.49 |
| Alok Industries | 27.4 | -2.66 |
Is Atara a good stock?
Atara Biotherapeutics, Inc.
may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of ATRA, demonstrate its potential to underperform the market. It currently has a Growth Score of C.
Which share to buy for 10 years?
| Stock Name | Sub-sector | Market Cap (in Cr) |
|---|---|---|
| Bajaj Finance Ltd | Consumer Finance | ₹4,48,641.51 |
| Titan Company Ltd | Textiles, Apparel & Luxury Goods | ₹3,28,263 |
| Varun Beverages Ltd | Beverages | ₹1,66,364 |
| Cholamandalam Investment and Finance Company Ltd | Financials | ₹99,434 |
What stock will go up the most in 10 years?
| Stock | Forward price-to-earnings ratio (P/E) |
|---|---|
| Chipotle Mexican Grill Inc. (CMG) | 43.0 |
| Costco Wholesale Corp. (COST) | 40.0 |
| CrowdStrike Holdings Inc. (CRWD) | 73.8 |
| Enphase Energy Inc. (ENPH) | 25.3 |
How much will stocks grow in 10 years?
| Period (start-of-year to end-of-2023) | Average annual S&P 500 return |
|---|---|
| 5 years (2019-2023) | 15.36% |
| 10 years (2014-2023) | 11.02% |
| 15 years (2009-2023) | 12.63% |
| 20 years (2004-2023) | 9.00% |
Who owns the most MARA stock?
| Holder | Shares | Date Reported |
|---|---|---|
| Vanguard Group Inc | 23,473,587 | Dec 30, 2023 |
| Blackrock Inc. | 17,192,377 | Dec 30, 2023 |
| Jane Street Group, LLC | 8,476,200 | Dec 30, 2023 |
| Morgan Stanley | 6,271,139 | Dec 30, 2023 |
What will Terra be worth in 2030?
The Terra price prediction for 2030 is between $ 2.93 on the lower end and $ 4.75 on the high end. Based on our LUNA price prediction chart, the price of Terra could gain 320.81% and reach $ 4.75 if it reaches the upper price target.
Is MARA a good stock to buy right now?
The financial health and growth prospects of MARA, demonstrate its potential to underperform the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of D.
Who owns ATRA?
The ownership structure of Atara Biotherapeutics (ATRA) stock is a mix of institutional, retail and individual investors. Approximately 43.29% of the company's stock is owned by Institutional Investors, 9.41% is owned by Insiders and 47.30% is owned by Public Companies and Individual Investors.
What is the stock price prediction for gevo in 2025?
Gevo Stock Prediction 2025
The Gevo stock prediction for 2025 is currently $ 0.430758, assuming that Gevo shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -35.83% increase in the GEVO stock price.
What will ET stock be worth in 5 years?
Energy Transfer stock price stood at $15.34
According to the latest long-term forecast, Energy Transfer price will hit $17 by the end of 2024 and then $20 by the end of 2026. Energy Transfer will rise to $25 within the year of 2028, $30 in 2030 and $35 in 2034.
What does Atara do?
Atara is an allogeneic T-cell immunotherapy company. We're harnessing the natural biology of T cells—our body's most effective weapon in fighting disease—to develop transformative therapies for patients with cancer and autoimmune conditions.
How high will ET stock go?
Energy Transfer LP Stock Forecast
The 7 analysts with 12-month price forecasts for Energy Transfer LP stock have an average target of 17.14, with a low estimate of 14 and a high estimate of 22.
Should I buy purple stock?
Purple Innovation's analyst rating consensus is a Moderate Buy. This is based on the ratings of 4 Wall Streets Analysts.
When did Atara Biotherapeutics go public?
Atara Biotherapeutics went public on October 15, 2014. How can I purchase shares? Shares can be purchased through a stockbroker of your choice.
What is the net worth of Atara Biotherapeutics?
Atara Biotherapeutics has a market cap or net worth of $75.45 million as of March 4, 2024. Its market cap has decreased by -81.58% in one year.
Who founded Atara Biotherapeutics?
Atara Biotherapeutics Founders
Isaac Ciechanover E. Dr. Isaac Ciechanover E. is a Chief Executive Officer at ATARA BIOTHERAPEUTICS INC and is based in United States.
References
- https://investors.atarabio.com/atra-stock/faq
- https://www.atarabio.com/
- https://www.zacks.com/stock/research/ATRA/stock-style-scores
- https://stockanalysis.com/stocks/et/forecast/
- https://coincodex.com/stock/OPEN/price-prediction/
- https://www.nerdwallet.com/article/investing/average-stock-market-return
- https://investorplace.com/2023/11/why-is-atara-biotherapeutics-atra-stock-down-50-today/
- https://coinpriceforecast.com/et-stock
- https://www.wallstreetzen.com/stocks/us/nasdaq/atra/stock-forecast
- https://www.smallcase.com/collections/long-term-stocks-to-buy/
- https://markets.businessinsider.com/stocks/atra-stock
- https://coincodex.com/stock/MARA/price-prediction/
- https://coincodex.com/stock/GEVO/price-prediction/
- https://www.zippia.com/atara-biotherapeutics-careers-1042/executives/
- https://www.tipranks.com/stocks/prpl/forecast
- https://stockanalysis.com/stocks/atra/market-cap/
- https://www.zacks.com/stock/research/MARA/stock-style-scores
- https://www.5paisa.com/share-market-today/penny-stocks
- https://finance.yahoo.com/quote/MARA/holders/
- https://www.tipranks.com/stocks/atra/ownership
- https://coincodex.com/stock/ATRA/price-prediction/
- https://coincodex.com/crypto/terra-luna-v2/price-prediction/
- https://www.tipranks.com/stocks/atra/forecast
- https://money.usnews.com/investing/articles/best-growth-stocks-for-the-next-ten-years
